Although there was no verbatim basis in the application as originally filed for the feature, the specific monoclonal antibodies of claim 6 were thus implicitly disclosed in the application as filed.Auxiliary request 1, claim 10 for all designated Contracting States except ES and GR, Article 123(3) EPC- The scope of protection conferred by claim 10 did not extend the protection conferred by either